AACR applauds NCI initiative on nanotechnology

September 13, 2004

To better understand the molecular steps that result in cancer and its spread, scientists and clinicians increasingly are turning to smaller and smaller probes that not only act as microscopic sentinels, but also as tools capable of interfering with these processes.

For this reason, the American Association for Cancer Research applauds the new initiative announced today by the National Cancer Institute to harness the power of nanotechnology in the fight against cancer.

"Nanotechnology can serve as an effective complement to approaches including proteomics and bioinformatics that will become critical components in the near- and long-term progress in cancer diagnostics, treatment and prevention," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of AACR.

As outlined, the NCI Alliance for Nanotechnology in Cancer will provide $144.3 million over five years to bring together researchers, clinicians and public and private organizations to translate cancer-related nanotechnology research for the benefit of the patient. Nanotechnology refers to the interactions of cellular and molecular components and engineered materials - typically clusters of atoms, molecules and molecular fragments - at the most elemental level of biology. Such nanoscale objects can be useful by themselves or as part of larger devices containing multiple nanoscale objects.

The new effort is designed to enhance cross-disciplinary and cross-sector collaborations in nanotechnology, which scientists now believe is poised for prime time application.

"Engineers, physicists, chemists and material scientists will now be able to work closely with biologists and cancer researchers to create nanotechnology devices capable of probing the inner sanctum of the cell and the multifactorial process that leads to cancer and metastasis," said Lynn M. Matrisian, Ph.D., president of the AACR. "Such collaborations are essential if we are going to make the advances against cancer we believe are possible in the near future.

"We in the cancer research community must reach out to scientists and experts from any discipline that offers new ways of understanding, interfering with and ultimately curing cancer. This nanotechnology initiative provides an important new model for how to do this."
-end-
Founded in 1907, the American Association for Cancer Research is a professional society of more than 24,000 laboratory, translational, and clinical scientists engaged in all areas of cancer research in the United States and in more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals, Cancer Research, Clinical Cancer Research, Molecular Cancer Therapeutics, Molecular Cancer Research, and Cancer Epidemiology, Biomarkers & Prevention. AACR's Annual Meeting attracts more than 15,000 participants who share new and significant discoveries in the cancer field. Specialty meetings, held throughout the year, focus on the latest developments in all areas of cancer research.

American Association for Cancer Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.